Leo Pharma's climate targets receive science-based stamp of approval

The Science Based Targets initiative has approved Leo Pharma’s emission reduction targets to combat climate change.
by andreas lønstrup, translated by daniel pedersen

Leo Pharma has announced in a press release that its emission reduction targets have been validated by the Science Based Targets initiative (SBTi), which is a collaboration between the World Resources Institute, UN Global Compact and the World Wide Fund (WWF) and more.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading